These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 20508188)
1. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Kamel H; Hegde M; Johnson DR; Gage BF; Johnston SC Stroke; 2010 Jul; 41(7):1514-20. PubMed ID: 20508188 [TBL] [Abstract][Full Text] [Related]
2. Letter by Wachter et al regarding article "Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke". Wachter R; Stahrenberg R; Gröschel K Stroke; 2011 Mar; 42(3):e36; author reply e37. PubMed ID: 21273570 [No Abstract] [Full Text] [Related]
3. Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke. Yong JH; Thavorn K; Hoch JS; Mamdani M; Thorpe KE; Dorian P; Sharma M; Laupacis A; Gladstone DJ; Stroke; 2016 Sep; 47(9):2380-5. PubMed ID: 27470989 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Kamel H; Johnston SC; Easton JD; Kim AS Stroke; 2012 Mar; 43(3):881-3. PubMed ID: 22308255 [TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke. Levin LÅ; Husberg M; Sobocinski PD; Kull VF; Friberg L; Rosenqvist M; Davidson T Europace; 2015 Feb; 17(2):207-14. PubMed ID: 25349228 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective. Chevalier J; Delaitre O; Hammès F; de Pouvourville G Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113 [TBL] [Abstract][Full Text] [Related]
7. Continuous monitoring versus HOLTER ECG for detection of atrial fibrillation in patients with stroke. Gumbinger C; Krumsdorf U; Veltkamp R; Hacke W; Ringleb P Eur J Neurol; 2012 Feb; 19(2):253-7. PubMed ID: 21895885 [TBL] [Abstract][Full Text] [Related]
8. Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Grond M; Jauss M; Hamann G; Stark E; Veltkamp R; Nabavi D; Horn M; Weimar C; Köhrmann M; Wachter R; Rosin L; Kirchhof P Stroke; 2013 Dec; 44(12):3357-64. PubMed ID: 24130137 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Liao J; Khalid Z; Scallan C; Morillo C; O'Donnell M Stroke; 2007 Nov; 38(11):2935-40. PubMed ID: 17901394 [TBL] [Abstract][Full Text] [Related]
10. Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective. Maervoet J; Bossers N; Borge RP; Hilpert ST; van Engen A; Smala A J Med Econ; 2019 Nov; 22(11):1221-1234. PubMed ID: 31480905 [No Abstract] [Full Text] [Related]
11. Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia. Mayer F; Stahrenberg R; Gröschel K; Mostardt S; Biermann J; Edelmann F; Liman J; Wasem J; Goehler A; Wachter R; Neumann A Clin Res Cardiol; 2013 Dec; 102(12):875-84. PubMed ID: 23904073 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia. Ademi Z; Pasupathi K; Liew D Eur J Prev Cardiol; 2015 Mar; 22(3):344-53. PubMed ID: 24281250 [TBL] [Abstract][Full Text] [Related]
13. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation. O'Brien CL; Gage BF JAMA; 2005 Feb; 293(6):699-706. PubMed ID: 15701911 [TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of extended electrocardiogram monitoring for atrial fibrillation in patients with cryptogenic stroke. Chew DS; Rennert-May E; Quinn FR; Buck B; Hill MD; Spackman E; Manns BJ; Exner DV Int J Stroke; 2021 Oct; 16(7):809-817. PubMed ID: 33232196 [TBL] [Abstract][Full Text] [Related]
15. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. Miller DJ; Khan MA; Schultz LR; Simpson JR; Katramados AM; Russman AN; Mitsias PD J Neurol Sci; 2013 Jan; 324(1-2):57-61. PubMed ID: 23102659 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. Diamantopoulos A; Sawyer LM; Lip GY; Witte KK; Reynolds MR; Fauchier L; Thijs V; Brown B; Quiroz Angulo ME; Diener HC Int J Stroke; 2016 Apr; 11(3):302-12. PubMed ID: 26763916 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570 [TBL] [Abstract][Full Text] [Related]
18. Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection. Edwards JD; Kapral MK; Fang J; Saposnik G; Gladstone DJ; Stroke; 2016 Aug; 47(8):1982-9. PubMed ID: 27406109 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and paroxysmal atrial fibrillation detection in patients with acute ischemic stroke. Sutamnartpong P; Dharmasaroja PA; Ratanakorn D; Arunakul I J Stroke Cerebrovasc Dis; 2014; 23(5):1138-41. PubMed ID: 24189453 [TBL] [Abstract][Full Text] [Related]
20. Optimal timing and duration of continuous electrocardiographic monitoring for detecting atrial fibrillation in stroke patients. Suissa L; Lachaud S; Mahagne MH J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):991-5. PubMed ID: 22349706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]